Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats

Journal of Gastroenterology

Volumn 43, Issue 1, 2008, Pages 79-85

  Ishibashi, Toshiaki ^a   Zhao, Haifeng ^a   Kawabe, Ken ^a   Oono, Takamasa ^a   Egashira, Kensuke ^a   Suzuki, Koichi ^b   Nawata, Hajime ^a   Takayanagi, Ryoichi ^a   Ito, Tetsuhide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Acute pancreatitis; Chemokines; Monocyte chemoattractant protein 1

Indexed keywords

AMYLASE; CERULETIDE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TAUROCHOLIC ACID; TRYPSIN;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG ACTIVITY; EXPRESSION VECTOR; HISTOPATHOLOGY; LUNG; MALE; MORPHOLOGY; MUTANT; NONHUMAN; NONVIRAL GENE THERAPY; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SURVIVAL RATE;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CAERULEIN; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; INJECTIONS; MALE; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 40149093890     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2126-9     Document Type: Article

References (32)

1. Yamauchi J, Shibuya K, Sunamura M, Arai K, Shimamura H, Motoi F, et al. Cytokine modulation in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001;8:195-203.
2. Rau B, Baumgart K, Kruger CM, Schilling M, Beger HG. CC-chemokine activation in acute pancreatitis: Enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med 2003;29:622-629.
3. Papachristou GI, Sass DA, Avula H, Lamb J, Lokshin A, Barmada MM, et al. Is the monocyte chemotactic protein-1-2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005;3:475-481.
4. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000;190:117-125.
5. Valente AJ, Rozek MM, Schwartz CJ, Graves DT. Characterization of monocyte chemotactic protein-1 binding to human monocytes. Biochem Biophys Res Commun 1991;176:309-314.
6. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. Monocyte chemotactic protein-1 (MCP-1),-2, and-3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370-1376.
7. Bhatia M, Proudfoot AE, Wells TN, Christmas S, Neoptolemos JP, Slavin J. Treatment with Met-RANTES reduces lung injury in caerulein-induced pancreatitis. Br J Surg 2003;90:698-704.
8. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, et al. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 1997;100:2022-2027.
9. Bhatia M, Brady M, Zagorski J, Christmas SE, Campbell F, Neoptolemos JP, et al. Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 2000;47:838-844.
10. Osman MO, Kristensen JU, Jacobsen NO, Lausten SB, Deleuran B, Deleuran M, et al. A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut. 1998;43:232-239.
11. Bhatia M, Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G1259-1265.
12. Zhang Y, Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 1995;15:4851-4855.
13. Zhang YJ, Rutledge BJ, Rollins BJ. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem 1994;269:15918-15924
14. Rollins BJ. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996;2:198-204.
15. Egashira K, Koyanagi M, Kitamoto S, Ni W, Kataoka C, Morishita R, et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: Blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J 2000;14:1974-1978.
16. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-230.
17. Ogoshi K, Ito T, Igarashi H, Arita Y, Hisano T, Sumii T, et al. The time course of gap-junctional protein connexin 32 expression in the pancreas after the induction of acute pancreatitis by caerulein in rats. J Gastroenterol 2002;37:633-639.
18. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions. Clin Chim Acta 1969;26:437-444.
19. Beger HG, Rau B, Isenmann R. Natural history of necrotizing pancreatitis. Pancreatology 2003;3:93-101.
20. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg 1997;21:130-135.
21. Saluja AK, Steer MLP. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 1999;60(suppl 1):27-33.
22. Andersson R, Deng XM, Wang XD. Role of macrophage overactivation in the development of acute pancreatic injury in rats. Br J Surg 1997;84:775-780.
23. Yang J, Denham W, Tracey KJ, Wang H, Kramer AA, Salhab KF, et al. The physiologic consequences of macrophage pacification during severe acute pancreatitis. Shock 1998;10:169-175.
24. Yang J, Denham W, Carter G, Tracey KJ, Norman J. Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor alpha and interleukin-1beta. Hepatology 1998;28:1282-1288.
25. Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966-1975.
26. Brady M, Bhatia M, Christmas S, Boyd MT, Neoptolemos JP, Slavin J. Expression of the chemokines MCP-1/JE and cytokineinduced neutrophil chemoattractant in early acute pancreatitis. Pancreas 2002;25:260-269.
27. Bhatia M, Brady M, Kang YK, Costello E, Newton DJ, Christmas SE, et al. MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation. Am J Physiol Gastrointest Liver Physiol 2002;282:G77-85.
28. Inoue M, Ino Y, Gibo J, Ito T, Hisano T, Arita Y, et al. The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002;25:e64-70.
29. Zhao HF, Ito T, Gibo J, Kawabe K, Oono T, Kaku T, et al. Antimonocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Gut 2005;54:1759-1767.
30. Ito T. Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis? J Gastroenterol 2007;42(suppl 17):72-77.
31. Ward JB, Sutton R, Jenkins SA, Petersen OH. Progressive disruption of acinar cell calcium signaling is an early feature of cerulein-induced pancreatitis in mice. Gastroenterology 1996;111:481-491.
32. Ueda T, Takeyama Y, Kaneda K, Adachi M, Ohyanagi H, Saitoh Y. Protective effect of a microtubule stabilizer taxol on ceruleininduced acute pancreatitis in rat. J Clin Invest 1992;89:234-243.